METHOD FOR ASSESSING DECAY OF SEROTONIN CONTENT IN PREGNANT WOMEN'S PERIPHERAL BLOOD IN THIRD TRIMESTER OF GESTATION WITH HERPES VIRUS INFECTION BY HUMAN IMMUNOGLOBULIN THERAPY

METHOD FOR ASSESSING DECAY OF SEROTONIN CONTENT IN PREGNANT WOMEN'S PERIPHERAL BLOOD IN THIRD TRIMESTER OF GESTATION WITH HERPES VIRUS INFECTION BY HUMAN IMMUNOGLOBULIN THERAPY

FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to obstetrics and gynaecology, and can be used for reducing a risk of the foetoplacental system organs involvement in the third trimester of gestation in aggravated herpes viral infection in the 12week of gestation. That is ensured by i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ANDRIEVSKAJA IRINA ANATOL'EVNA, LUTSENKO MIKHAIL TIMOFEEVICH
Format: Patent
Sprache:eng ; rus
Schlagworte:
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
TESTING
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to obstetrics and gynaecology, and can be used for reducing a risk of the foetoplacental system organs involvement in the third trimester of gestation in aggravated herpes viral infection in the 12week of gestation. That is ensured by intravenous drop-by-drop infusion of human immunoglobulin 25 ml in the 16and 24weeks of pregnancy three times every second day.EFFECT: method enables reducing the foetoplacental system organs involvement by preventing a great amount of serotonin. Изобретение относится к медицине, а именно к акушерству и гинекологии, и может быть использовано для уменьшения риска повреждения органов фетоплацентарной системы в третьем триместре гестации при обострении герпес-вирусной инфекции на 12 неделе гестации. Для этого на 16 и 24 неделях беременности внутривенно вводят человеческий иммуноглобулин по 25 мл капельно трижды через день. Способ позволяет уменьшить повреждение органов фетоплацентарной системы за счет предотвращения появления большого количества серотонина.